Andrew Arno - 01 Jul 2026 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (IMDX)

Reporting relationship: Director
Issuer ticker: IMDX
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 20:35:43 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Arno

Key filing fact

Andrew Arno filed Form 4 for Insight Molecular Diagnostics Inc. (IMDX) on 06 Jul 2026.

Key facts

This page summarizes Andrew Arno's Form 4 filing for Insight Molecular Diagnostics Inc. (IMDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 20:35.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001472122 Primary reporting owner

Arno Andrew

Relationship: Director
Address: C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE
Signature: /s/ Andrew Arno
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMDX transaction

Common Stock, no par value

Tax liability

Transaction value
Shares: -12,100
Change %: -7.2%
Price: $5.69^*
Shares after: 156,785
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

IMDX holding

Common Stock, no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,804
Date: 01 Jul 2026
Ownership: See footnote
Footnotes: F2

IMDX holding

Common Stock, no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,804
Date: 01 Jul 2026
Ownership: See footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 55,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

Footnote F2

These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.

Footnote F3

These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.